Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene

Clinical Cancer Research

Volumn 4, Issue 3, 1998, Pages 731-741

  Yang, Lily ^a   Hwang, Rosa ^a   Chiang, Yawen ^c   Gordon, Erlinda M ^a   Anderson, W French ^a   Parekh, Dilip ^b  

^a Gene Therapy Laboratories   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; GASTROINTESTINAL CARCINOMA; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PANCREAS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; STOMACH CARCINOMA; SUICIDE GENE; VIRUS GENE; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; KINETICS; PANCREATIC NEOPLASMS; RETROVIRIDAE; SIMPLEXVIRUS; STOMACH NEOPLASMS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0031949646     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Martin, L. A., and Lemoine, N. R. Direct cell killing by suicide genes. Cancer Metastasis Rev., 15: 301-316, 1996.
2. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
3. Smythe, R. W., Hwang, H. C., Elshami, A. A., Amin, K. M., Eck, S. L., Davidson, B. L., Wilson, J. M., Kaiser, L. R., and Albelda, S. M. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann. Surg., 222: 78-86, 1995.
4. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Saizmann, J. L., and Klatzmann, D. Regression of established macroscopic liver metastases after in situ transduction of suicidal gene. Proc. Natl. Acad. Sci. USA, 80: 7024-7028, 1993.
5. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
6. Freeman, S. C., Whartenby, K. A., Freeman, J. L., Abboud, C. N., and Marrogi, A. J. In situ use of suicide tenes for cancer therapy. Semin. Oncol., 23: 31-45, 1996.
7. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
8. Fick, J., Barker, F. G., II, Dazin, P., Westphale, E. M., Beyer, E. C., and Israel, M. A. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci. USA, 92: 11071-11075, 1995.
9. Pitts, J. D. Cancer gene therapy: a bystander effect using the gap junctional pathway. Mol. Carcinog., 11: 127-130, 1994.
10. Moolten, F. L., Wells, J. M., Heyman, R. A., and Evans, R. M. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther., 1: 125-134, 1990.
11. Barbar, D., Hardin, J., Ray, J., and Gage, F. H. Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg, 79: 729-735, 1993.
12. Chou, S., Erice, A., Jordan, M. C., Vercellotti, G. M., Michels, D. R., Talarico, C. L., Stanat, S. C., and Biron, K. K. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis., 171: 576-583, 1995.
13. Wolf, D. G., Smith, I. L., Lee, D. J., Freeman, W. R., Flores-Aguilar, M., and Spector, S. A. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J. Clin. Invest., 95: 257-263, 1995.
14. Challita, P. A., and Kohn, D. B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA, 91: 2567-2571, 1994.
15. Tiberghien, P., Reynolds, C. W., Keller, J. R., Murphy, B., Lyons, R., Chiang, Y., Longo, D. L., and Ruscetti, F. W. Growth inhibition of herpes simplex thymidine kinase (Hs-tk)-transduced primary T lymphocytes by ganciclovir (GCV): lack of a bystander effect. Proc. Am. Assoc. Cancer Res., 34: 338, 1993.